ALL
Pharma in China
Pharma Experts
Market News
Products Guide
Brand Story
-
REVLIMID® Approved by the European Commission as Monotherapy for the Maintenance Treatment of Patien
February 27, 2017Celgene International Sàrl, a wholly-owned subsidiary of Celgene Corporation announced that the European Commission (EC) has approved REVLIMID® (lenalidomide) as monotherapy for the maintenance treatment of adult patients with newly diagnosed multiple mye
Pharma Sources Insight January 2025
